Skip to content
Subscriber Only
Business
Prognosis

U.S. Decline Levels Off; J&J Shot Gets Panel’s Nod: Virus Update

Updated on

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

The recent decline in U.S. cases and deaths appears to be leveling off, and cases have begun to rise across a swath of states. A panel of government advisers backed Johnson & Johnson’s single-shot vaccine, paving the way for authorization of a third U.S. immunization against the virus.